insights_auto
Why is RCEL up 6.39%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$13.98
arrow_upward
+6.39%(+0.84) 1D
Oct 20, 2:15:13 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$13.29
High
$14.08
Low
$13.29
Mkt. cap
432.36M
Avg. vol.
321.85K
Volume
218.57K
52-wk high
$14.08
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
Open
$13.29
High
$14.08
Low
$13.29
Mkt. cap
432.36M
Avg. vol.
321.85K
Volume
218.57K
52-wk high
$14.08
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Unusual Volume Movers for October 20
TradingView
·
1 hour ago
S&P 500 Could Hit 8,300 By May 2027, Says Morgan Stanley Investment Chief Predicting ‘Final Innings’ Of Stock Market Correction
Yahoo Finance
·
1 hour ago
United Therapeutics (UTHR): Can the Profit-Machine Biotech Finally Crack the S&P 500?
Insider Monkey
·
57 minutes ago
Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com